• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2017年塞内加尔的体外环孢子蛋白抗原变异分析(RSA)和恶性疟原虫Kelch13靶向扩增子深度测序揭示了疟原虫对青蒿素的敏感性。

Ex vivo RSA and Pfkelch13 targeted-amplicon deep sequencing reveal parasites susceptibility to artemisinin in Senegal, 2017.

作者信息

Yade Mamadou Samb, Dièye Baba, Coppée Romain, Mbaye Aminata, Diallo Mamadou Alpha, Diongue Khadim, Bailly Justine, Mama Atikatou, Fall Awa, Thiaw Alphonse Birane, Ndiaye Ibrahima Mbaye, Ndiaye Tolla, Gaye Amy, Tine Abdoulaye, Diédhiou Younouss, Mbaye Amadou Mactar, Doderer-Lang Cécile, Garba Mamane Nassirou, Bei Amy Kristine, Ménard Didier, Ndiaye Daouda

机构信息

Centre International de Recherche et de Formation en Génomique Appliquée, et de Surveillance Sanitaire (CIGASS), Cheikh Anta Diop University of Dakar.

Université Paris Cité and Sorbone Paris Nord, Inserm, IAME.

出版信息

Res Sq. 2023 Feb 6:rs.3.rs-2538775. doi: 10.21203/rs.3.rs-2538775/v1.

DOI:10.21203/rs.3.rs-2538775/v1
PMID:36798264
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9934778/
Abstract

INTRODUCTION

Malaria control is highly dependent on the effectiveness of artemisinin-based combination therapies (ACTs), the current frontline malaria curative treatments. Unfortunately, the emergence and spread of parasites resistant to artemisinin (ART) derivatives in Southeast Asia and South America, and more recently in Rwanda and Uganda (East Africa), compromise their long-term use in Sub-Saharan Africa where most malaria deaths occur.

METHODS

Here, we evaluated susceptibility to dihydroartemisinin (DHA) from 38 isolates collected in 2017 in Thiès (Senegal) expressed with the Ring-stage Survival Assay (RSA). We explored major and minor variants in the full gene, the main determinant of ART resistance using a targeted-amplicon deep sequencing (TADS) approach.

RESULTS

All samples tested in the RSA were found to be susceptible to DHA. Both non-synonymous mutations K189T and K248R were observed each in one isolate, as major (99%) or minor (5%) variants, respectively.

CONCLUSION

Altogether, investigations combining RSA and TADS are a useful approach for monitoring ART resistance in Africa.

摘要

引言

疟疾控制高度依赖于以青蒿素为基础的联合疗法(ACTs)的有效性,这是目前治疗疟疾的一线疗法。不幸的是,东南亚和南美洲,以及最近在卢旺达和乌干达(东非)出现并传播了对青蒿素(ART)衍生物耐药的寄生虫,这危及了它们在撒哈拉以南非洲的长期使用,而撒哈拉以南非洲是疟疾死亡人数最多的地区。

方法

在此,我们使用环期存活测定法(RSA)评估了2017年在塞内加尔捷斯采集的38株分离株对双氢青蒿素(DHA)的敏感性。我们采用靶向扩增子深度测序(TADS)方法,探究了全长基因中的主要和次要变异,全长基因是ART耐药性的主要决定因素。

结果

在RSA中测试的所有样本均被发现对DHA敏感。在一个分离株中分别观察到非同义突变K189T和K248R,分别作为主要(99%)或次要(5%)变异。

结论

总之,将RSA和TADS相结合的调查是监测非洲ART耐药性的一种有用方法。

相似文献

1
Ex vivo RSA and Pfkelch13 targeted-amplicon deep sequencing reveal parasites susceptibility to artemisinin in Senegal, 2017.2017年塞内加尔的体外环孢子蛋白抗原变异分析(RSA)和恶性疟原虫Kelch13靶向扩增子深度测序揭示了疟原虫对青蒿素的敏感性。
Res Sq. 2023 Feb 6:rs.3.rs-2538775. doi: 10.21203/rs.3.rs-2538775/v1.
2
Ex vivo RSA and pfkelch13 targeted-amplicon deep sequencing reveal parasites susceptibility to artemisinin in Senegal, 2017.2017 年塞内加尔的体外 RSA 和 pfkelch13 靶向扩增子深度测序显示寄生虫对青蒿素的敏感性。
Malar J. 2023 May 26;22(1):167. doi: 10.1186/s12936-023-04588-1.
3
Assessment of artemisinin tolerance in Plasmodium falciparum clinical isolates in children with uncomplicated malaria in Ghana.加纳单纯性疟疾患儿恶性疟原虫临床分离株对青蒿素耐受性的评估。
Malar J. 2023 Feb 19;22(1):58. doi: 10.1186/s12936-023-04482-w.
4
Genetic background and PfKelch13 affect artemisinin susceptibility of PfCoronin mutants in Plasmodium falciparum.遗传背景和 PfKelch13 对疟原虫 PfCoronin 突变体对青蒿素敏感性的影响。
PLoS Genet. 2020 Dec 28;16(12):e1009266. doi: 10.1371/journal.pgen.1009266. eCollection 2020 Dec.
5
Insight into k13-propeller gene polymorphism and ex vivo DHA-response profiles from Cameroonian isolates.喀麦隆分离株K13螺旋桨基因多态性及体外DHA反应谱的研究
Malar J. 2016 Nov 26;15(1):572. doi: 10.1186/s12936-016-1622-x.
6
Mutations in Huambo, Angola.安哥拉万博的突变。
Pathogens. 2022 May 8;11(5):554. doi: 10.3390/pathogens11050554.
7
Tolerance of Gambian Plasmodium falciparum to Dihydroartemisinin and Lumefantrine Detected by Parasite Survival Rate Assay.寄生虫存活率检测法发现冈比亚疟原虫对双氢青蒿素和咯萘啶的耐受性。
Antimicrob Agents Chemother. 2020 Dec 16;65(1). doi: 10.1128/AAC.00720-20.
8
Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies.柬埔寨青蒿素耐药性恶性疟原虫的新型表型检测方法:体外和体内药物反应研究。
Lancet Infect Dis. 2013 Dec;13(12):1043-9. doi: 10.1016/S1473-3099(13)70252-4. Epub 2013 Sep 11.
9
Artemisinin resistance without pfkelch13 mutations in Plasmodium falciparum isolates from Cambodia.柬埔寨恶性疟原虫分离株中无pfkelch13突变的青蒿素抗性
Malar J. 2017 May 12;16(1):195. doi: 10.1186/s12936-017-1845-5.
10
Molecular assessment of kelch13 non-synonymous mutations in Plasmodium falciparum isolates from Central African Republic (2017-2019).中非共和国(2017-2019 年)疟原虫分离株中 kelch13 非同义突变的分子评估。
Malar J. 2020 May 24;19(1):191. doi: 10.1186/s12936-020-03264-y.

本文引用的文献

1
Circulation of an Artemisinin-Resistant Malaria Lineage in a Traveler Returning from East Africa to France.从东非返回法国的旅行者中出现抗青蒿素疟疾谱系的传播。
Clin Infect Dis. 2022 Sep 30;75(7):1242-1244. doi: 10.1093/cid/ciac162.
2
Mutation in the Plasmodium falciparum BTB/POZ Domain of K13 Protein Confers Artemisinin Resistance.疟原虫 K13 蛋白 BTB/POZ 结构域的突变导致对青蒿素的耐药性。
Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0132021. doi: 10.1128/AAC.01320-21. Epub 2021 Oct 4.
3
Evidence of Artemisinin-Resistant Malaria in Africa.非洲出现青蒿素抗药性疟疾。
N Engl J Med. 2021 Sep 23;385(13):1163-1171. doi: 10.1056/NEJMoa2101746.
4
High Prevalence of Plasmodium falciparum K13 Mutations in Rwanda Is Associated With Slow Parasite Clearance After Treatment With Artemether-Lumefantrine.卢旺达恶性疟原虫 K13 突变的高流行率与青蒿琥酯-咯萘啶治疗后寄生虫清除缓慢有关。
J Infect Dis. 2022 Apr 19;225(8):1411-1414. doi: 10.1093/infdis/jiab352.
5
Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine and polymorphism in Plasmodium falciparum kelch13-propeller gene in Equatorial Guinea.青蒿琥酯-阿莫地喹和青蒿琥酯-甲氟喹的治疗效果及赤道几内亚恶性疟原虫 Kelch13-螺旋桨基因多态性。
Malar J. 2021 Jun 22;20(1):275. doi: 10.1186/s12936-021-03807-x.
6
Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study.在卢旺达,恶性疟原虫kelch13 R561H 基因型与寄生虫清除延迟的关联:一项开放标签、单臂、多中心、治疗效果研究。
Lancet Infect Dis. 2021 Aug;21(8):1120-1128. doi: 10.1016/S1473-3099(21)00142-0. Epub 2021 Apr 14.
7
Prevalence of pfk13 and pfmdr1 polymorphisms in Bounkiling, Southern Senegal.塞内加尔南部布恩基林地区 pfk13 和 pfmdr1 多态性的流行情况。
PLoS One. 2021 Mar 26;16(3):e0249357. doi: 10.1371/journal.pone.0249357. eCollection 2021.
8
Increase in Kelch 13 Polymorphisms in Plasmodium falciparum, Southern Rwanda.卢旺达南部疟原虫 Kelch13 多态性增加。
Emerg Infect Dis. 2021 Jan;27(1):294-296. doi: 10.3201/eid2701.203527.
9
Changing Prevalence of Potential Mediators of Aminoquinoline, Antifolate, and Artemisinin Resistance Across Uganda.乌干达各地潜在的氨基喹啉、抗叶酸和青蒿素耐药性中介体的流行率变化。
J Infect Dis. 2021 Mar 29;223(6):985-994. doi: 10.1093/infdis/jiaa687.
10
Spatial and molecular mapping of Pfkelch13 gene polymorphism in Africa in the era of emerging Plasmodium falciparum resistance to artemisinin: a systematic review.在出现抗青蒿素疟原虫的时代,对非洲 Pfkelch13 基因多态性的空间和分子映射:系统评价。
Lancet Infect Dis. 2021 Apr;21(4):e82-e92. doi: 10.1016/S1473-3099(20)30493-X. Epub 2020 Oct 27.